160 related articles for article (PubMed ID: 29312601)
1. Inhibition of hepatocellular carcinoma growth by blockade of glycosphingolipid synthesis.
Jennemann R; Federico G; Mathow D; Rabionet M; Rampoldi F; Popovic ZV; Volz M; Hielscher T; Sandhoff R; Gröne HJ
Oncotarget; 2017 Dec; 8(65):109201-109216. PubMed ID: 29312601
[TBL] [Abstract][Full Text] [Related]
2. Hepatic glycosphingolipid deficiency and liver function in mice.
Jennemann R; Rothermel U; Wang S; Sandhoff R; Kaden S; Out R; van Berkel TJ; Aerts JM; Ghauharali K; Sticht C; Gröne HJ
Hepatology; 2010 May; 51(5):1799-809. PubMed ID: 20432257
[TBL] [Abstract][Full Text] [Related]
3. Cell-specific in vivo functions of glycosphingolipids: lessons from genetic deletions of enzymes involved in glycosphingolipid synthesis.
Jennemann R; Gröne HJ
Prog Lipid Res; 2013 Apr; 52(2):231-48. PubMed ID: 23473748
[TBL] [Abstract][Full Text] [Related]
4. Blockade of Glycosphingolipid Synthesis Inhibits Cell Cycle and Spheroid Growth of Colon Cancer Cells In Vitro and Experimental Colon Cancer Incidence In Vivo.
Jennemann R; Volz M; Bestvater F; Schmidt C; Richter K; Kaden S; Müthing J; Gröne HJ; Sandhoff R
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638879
[TBL] [Abstract][Full Text] [Related]
5. Update on Glycosphingolipids Abundance in Hepatocellular Carcinoma.
Byrne FL; Olzomer EM; Lolies N; Hoehn KL; Wegner MS
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562868
[TBL] [Abstract][Full Text] [Related]
6. Increased glucosylceramide production leads to decreased cell energy metabolism and lowered tumor marker expression in non-cancerous liver cells.
Wegner MS; Schömel N; Olzomer EM; Trautmann S; Olesch C; Byrne FL; Brüne B; Gurke R; Ferreirós N; Weigert A; Geisslinger G; Hoehn KL
Cell Mol Life Sci; 2021 Nov; 78(21-22):7025-7041. PubMed ID: 34626204
[TBL] [Abstract][Full Text] [Related]
7. Early developmental expression of the gene encoding glucosylceramide synthase, the enzyme controlling the first committed step of glycosphingolipid synthesis.
Yamashita T; Wada R; Proia RL
Biochim Biophys Acta; 2002 Dec; 1573(3):236-40. PubMed ID: 12417405
[TBL] [Abstract][Full Text] [Related]
8. Glycosphingolipid synthesis in cerebellar Purkinje neurons: roles in myelin formation and axonal homeostasis.
Watanabe S; Endo S; Oshima E; Hoshi T; Higashi H; Yamada K; Tohyama K; Yamashita T; Hirabayashi Y
Glia; 2010 Aug; 58(10):1197-207. PubMed ID: 20544855
[TBL] [Abstract][Full Text] [Related]
9. Genetic Characterization of the Acidic and Neutral Glycosphingolipid Biosynthetic Pathways in
Shoma JF; Ernan B; Keiser G; Heiss C; Azadi P; Free SJ
Microorganisms; 2023 Aug; 11(8):. PubMed ID: 37630653
[TBL] [Abstract][Full Text] [Related]
10. Intravenous miR-144 inhibits tumor growth in diethylnitrosamine-induced hepatocellular carcinoma in mice.
He Q; Wang F; Honda T; Lindquist DM; Dillman JR; Timchenko NA; Redington AN
Tumour Biol; 2017 Oct; 39(10):1010428317737729. PubMed ID: 29072132
[TBL] [Abstract][Full Text] [Related]
11. Glucosylceramide Synthase Is Involved in Development of Invariant Natural Killer T Cells.
Popovic ZV; Rabionet M; Jennemann R; Krunic D; Sandhoff R; Gröne HJ; Porubsky S
Front Immunol; 2017; 8():848. PubMed ID: 28785267
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma.
Fang Y; Xue JL; Shen Q; Chen J; Tian L
Hepatology; 2012 Jun; 55(6):1852-62. PubMed ID: 22234835
[TBL] [Abstract][Full Text] [Related]
13. Cell-specific deletion of glucosylceramide synthase in brain leads to severe neural defects after birth.
Jennemann R; Sandhoff R; Wang S; Kiss E; Gretz N; Zuliani C; Martin-Villalba A; Jäger R; Schorle H; Kenzelmann M; Bonrouhi M; Wiegandt H; Gröne HJ
Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12459-64. PubMed ID: 16109770
[TBL] [Abstract][Full Text] [Related]
14. Nek7 is overexpressed in hepatocellular carcinoma and promotes hepatocellular carcinoma cell proliferation in vitro and in vivo.
Zhou L; Wang Z; Xu X; Wan Y; Qu K; Fan H; Chen Q; Sun X; Liu C
Oncotarget; 2016 Apr; 7(14):18620-30. PubMed ID: 26921196
[TBL] [Abstract][Full Text] [Related]
15. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells.
Zhao D; Zhai B; He C; Tan G; Jiang X; Pan S; Dong X; Wei Z; Ma L; Qiao H; Jiang H; Sun X
Cell Signal; 2014 May; 26(5):1030-9. PubMed ID: 24486412
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 inhibits cell proliferation in a rat model of hepatocellular carcinoma.
Moran DM; Mayes N; Koniaris LG; Cahill PA; McKillop IH
Liver Int; 2005 Apr; 25(2):445-57. PubMed ID: 15780071
[TBL] [Abstract][Full Text] [Related]
18. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis.
Qi R; An H; Yu Y; Zhang M; Liu S; Xu H; Guo Z; Cheng T; Cao X
Cancer Res; 2003 Dec; 63(23):8323-9. PubMed ID: 14678992
[TBL] [Abstract][Full Text] [Related]
19. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
[TBL] [Abstract][Full Text] [Related]
20. Vigilin is overexpressed in hepatocellular carcinoma and is required for HCC cell proliferation and tumor growth.
Yang WL; Wei L; Huang WQ; Li R; Shen WY; Liu JY; Xu JM; Li B; Qin Y
Oncol Rep; 2014 May; 31(5):2328-34. PubMed ID: 24676454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
